Arkolith/Insider Trading/NTLA/Form 4

Dube Michael P

VP, Chief Accounting OfficerIntellia Therapeutics, Inc. (NTLA) · full profile →Form 4 · filed Oct 4, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$38K
Net Open-Market Flow
-$38K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 2, 2024Sell(S)2K$19.01$38K47K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-112980) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML